Dr Shezad Malik Law Firm has offices based in Fort Worth and Dallas and represents people who have suffered catastrophic and serious personal injuries including wrongful death, caused by the negligence or recklessness of others. We specialize in Personal Injury trial litigation and focus our energy and efforts on those we represent.

Talcum Powder causes Ovarian Cancer? Depends on who you ask. According to Johnson and Johnson the maker of their flagship baby powder product and their follow up product, Shower to Shower, the answer is a resounding NO!

Talcum Powder causes Ovarian Cancer link

Medical research and jurors have found talcum powder ovarian cancer link.

But the jury asked to sit and weigh through the evidence presented in the third bellwether trial to take place in St. Louis would disagree vehemently.

A St. Louis jury yesterday announced a $70 million talcum powder ovarian cancer verdict, in the third talcum powder ovarian cancer case to go to trial.

Talcum Powder Ovarian Cancer link

Medical research and jurors have found talcum powder ovarian cancer link.

Deborah Giannecchini, 62, used Johnson & Johnson’s (J&J) baby powder for feminine hygiene for more than four decades until her diagnosis with ovarian cancer three years ago.

Giannecchini has an 80 percent chance of dying in the next two years, and has undergone surgery, radiation and chemotherapy.

J&J and Imerys Hammered

A J&J unit was ordered to pay $65 million in punitive damages and 90 percent of about $2.5 million for medical costs and pain and suffering.

Co-defendant Imerys Talc America, the supplier of the talc, was hit with $2.5 million in punitive damages.

Juror: “J&J Didn’t Care”

As reported in Bloomberg News, the company should have provided a warning label on the product to let consumers decide whether to use talc, one juror Billie Ray, 76, of St. Louis, said after the trial. “It seemed like Johnson & Johnson didn’t pay attention,” she said. “It seemed like they didn’t care.”

Continue reading

J&J Talcum Powder Ovarian Cancer link

Medical research and jurors found talcum powder Ovarian Cancer link.

Deborah Giannecchini of Modesto, California was awarded more than $70 million in her lawsuit alleging that years of using Johnson & Johnson’s baby powder made with talc caused her ovarian cancer.

Another Louisiana Taxotere hair loss lawsuit has been filed. The lawsuit was filed in the U.S. District Court for the Eastern District of Louisiana against Sanofi-Aventis over the failure to warn about the side effects of Taxotere.

Louisiana Taxotere hair loss lawsuit filed

Taxotere use in breast cancer chemotherapy associated with increased risk of permanent and horrendous hair loss.

According to Iris Guidry, in her Louisiana Taxotere hair loss lawsuit, claims that the chemotherapy drug Taxotere caused her to suffer permanent and horrendous hair loss, which is not associated with other effective breast cancer treatments.

Guidry claims that Sanofi-Aventis withheld critical information and warnings from patients and doctors about the risk that patients may experience permanent hair loss from Taxotere.

Hair Loss is common after Chemotherapy

Temporary hair loss is to be expected after chemotherapy, and the drug manufacturer claimed that hair grows back after Taxotere use. But, Guidry alleges that since she received breast cancer treatments involving Taxotere in 2011, she has continued hair loss side effects.

Taxotere Hair Loss Lawsuits

Many Taxotere failure to warn lawsuits are filed across the U.S., claiming that Sanofi-Aventis did not adequately disclose the risks of permanent and horrendous hair loss, providing reckless marketing statements. The lawsuits also claim that the drug manufacturer actively encouraged doctors to use Taxotere despite its risks and despite the availability of other, safer cancer treatments.

Continue reading

The Bard IVC Filter Injury lawsuits heading to trial set for 2017, according to the U.S. District Judge presiding over the coordinated pretrial proceedings in Phoenix, Arizona. Judge Campbell ruled that the first “bellwether” trial will probably go before a jury in fall of 2017. Since that date is a year away, more likely than not the date is liable to be moved as the cases get further developed.

Bard IVC Filter Injury lawsuits

Recent medical studies have linked IVC filters to serious injuries and death in severe cases.

Federal Multidistrict Litigation

Lawsuits filed throughout the federal court system over severe and catastrophic complications with Bard inferior vena cava (IVC) filters have been centralized in the U.S. District Court for the District of Arizona, since August 2015.

There are over 1,000 Bard IVC Filter injury lawsuits and wrongful death claims before Judge Campbell. These Bard IVC Filter injury lawsuits have similar claims; that patients suffered serious injuries and on occasion died after receiving a Bard G2, Bard Recovery, Bard Denali, Bard Eclipse, Bard Meridian or other Bard IVC filter for prevention of a pulmonary embolism.

What is the problem with IVC Filters? Continue reading

Stryker metal hip V40 implant failure lawsuits are being filed nationwide. According to confidential sources, another huge defective hip recall is coming down the pike and Stryker Orthopedics will face the brunt of it.

Stryker Metal Hip V40 Implant Failure Lawsuits

Stryker Metal Hip V40 Implant Failure Lawsuits

Stryker Metal Hip V40 Implant Failure Lawsuits

Stryker is exposed to another defective hip crisis associated with their total hip replacement medical devices, involving its large LFIT-V40 chrome/cobalt heads.

These metal alloy femoral hip heads have been reported to cause catastrophic dissociation (this is where the femoral head snaps off) or metallosis (metal poisoning) requiring emergency revision surgery. Stryker last faced a major hip device recall in 2012 with the recall of its popular Stryker Rejuvenate and Stryker ABGII modular hip stem devices.

Metal on metal hip implants have a high failure rate including those manufactured by Biomet, DePuy, Encore, Smith & Nephew, Stryker, Wright and Zimmer.

What is the Stryker V40 Head Hip Implant Defect problem?

Failure of the stem occurs from corrosion leading to erosion at the head-neck juncture of the Continue reading

The third bellwether DePuy Pinnacle Hip Failure trial has started this week. Johnson & Johnson and its DePuy Orthopaedics division are exposed to seven alleged defective metal on metal hip cases consolidated in Dallas, Northern District of Texas.

DePuy Pinnacle Hip Failure Lawsuits

Metal on metal hip implants have a high failure rate including those manufactured by Biomet, DePuy, Encore, Smith & Nephew, Stryker, Wright and Zimmer.

Metal on metal hip implants have a high failure rate including those manufactured by Biomet, DePuy, Encore, Smith & Nephew, Stryker, Wright and Zimmer.

DePuy Pinnacle Hip Failure $502 Million Verdict

Earlier this year, a Texas jury slammed DePuy Orthopedics over its failed Pinnacle metal hip implants, awarding $500 million. The DePuy Pinnacle hip implant is a metal-on-metal implant system that was found to fail prematurely, releasing particles of metal into surrounding tissue leading to inflammation and infection.

Why do Metal on Metal Hips Fail?

According to orthopedic experts, we have only seen the tip of the iceberg when it comes to painful revisions for failing metal on metal hip implants.

Metal on metal hip replacement and hip resurfacing, leads to particle debris from the cup and ball surfaces causing implant failure. As the implant patient moves, the surfaces of these two components grind against each other. The friction and abrasive wear and tear leads to debris production.

Metal-on-metal hip implants, where both the femoral component and the cup are made of metal Continue reading

nurseA recent medical study has shown that people who have taken Proton Pump Inhibitors (PPI), such as Prevacid, may be at an increased risk for chronic kidney disease.

A 2016 study published in the Journal of the American Medical Association (JAMA) shows that people who were taking the anti-ulcer medication Prevacid may be 20 to 50 percent more likely to experience chronic kidney disease than those not taking the medication. The study indicated that taking the medication more than once daily or for longer periods of time, increased the risk.

Concerns about Prevacid and other Proton Pump Inhibitor medications reach back to 2006 or before but the new results indicate that the risk of kidney failure is higher than previously thought. Researchers indicate that many patients taking the medications could have been discontinued without any adverse effects and that many prescriptions may have been given without a clear, medical diagnosis.

Xarelto GI Bleeding lawsuitsA federal judge in Louisiana has selected two lawsuits to serve as the first test trials amid more than 7,200 cases challenging the safety of Bayer AG and Johnson & Johnson subsidiary Janssen’s blockbuster blood thinner Xarelto.
The first trial, slated to start in February, involves claims Xarelto caused a Louisiana man to develop gastrointestinal bleeding, according to an order Friday from U.S. District Judge Eldon Fallon in the Eastern District of Louisiana.
The second trial will involve Joseph Orr, the husband of a woman who used Xarelto for about a month before she died from bleeding in the brain (cerebral hemorrhage). The cases will go to trial in Louisiana.

Androgel Stroke and Heart Attack AttorneyWith thousands of lawsuits involving testosterone products currently pending, eight of those cases have now been selected by a federal judge for early trials. Known as bellwether trials, these first lawsuits may provide insight into how juries will react to evidence and testimony in the more than 5,500 cases currently pending. In all of these lawsuits, plaintiffs are alleging use of testosterone products like Androgel have led to serious and even deadly side effects like heart attack and stroke.

U.S. District Judge Matthew F. Kennelly is currently overseeing around 5,500 lawsuits involving testosterone replacement therapies in the Northern District of Illinois. Plaintiffs in those cases have been prescribed testosterone products originally approved by the FDA to treat specific medical conditions that lead to a drop in testosterone levels in men. However, the drugs have also been used off-label to treat a wide range of symptoms related to the aging process, such as energy loss, decreased muscle mass and reduced libido.

The manufacturers of product like Testim, Axiron, and Androgel have touted their products as ant-aging formulas for a large percentage of men that suffer the symptoms associated with lower testosterone levels. The drugs come in a variety of forms, including patches, pellets, gels, and injections. While the products can indeed bring relief to men suffering from severely low testosterone levels, they can also increase the risk of heart attack, pulmonary embolism, stroke and death, particularly in men with a history of cardiovascular problems.

Contact Information